These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 15786885)
1. Can we get more HIV-positive tuberculosis patients on antiretroviral treatment in a rural district of Malawi? Zachariah R; Teck R; Ascurra O; Gomani P; Manzi M; Humblet P; Nunn P; Salaniponi FM; Harries AD Int J Tuberc Lung Dis; 2005 Mar; 9(3):238-47. PubMed ID: 15786885 [TBL] [Abstract][Full Text] [Related]
2. Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians. van Oosterhout JJ; Kumwenda JJ; Beadsworth M; Mateyu G; Longwe T; Burger DM; Zijlstra EE Antivir Ther; 2007; 12(4):515-21. PubMed ID: 17668560 [TBL] [Abstract][Full Text] [Related]
3. Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand. Sungkanuparph S; Manosuthi W; Kiertiburanakul S; Vibhagool A J Infect; 2006 Mar; 52(3):188-94. PubMed ID: 15992932 [TBL] [Abstract][Full Text] [Related]
4. Reasons for accepting or refusing HIV services among tuberculosis patients at a TB-HIV integration clinic in Malawi. Kumwenda M; Tom S; Chan AK; Mwinjiwa E; Sodhi S; Joshua M; van Lettow M Int J Tuberc Lung Dis; 2011 Dec; 15(12):1663-9. PubMed ID: 22118175 [TBL] [Abstract][Full Text] [Related]
5. Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport. Zachariah R; Harries AD; Manzi M; Gomani P; Teck R; Phillips M; Firmenich P PLoS One; 2006 Dec; 1(1):e121. PubMed ID: 17205125 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of anti-tuberculosis treatment among patients receiving highly active antiretroviral therapy at Vihiga district hospital in 2007. Kwange SO; Budambula NL Indian J Med Microbiol; 2010; 28(1):21-5. PubMed ID: 20061758 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of HIV-infected children with tuberculosis who are started on antiretroviral therapy in Malawi. Bong CN; Chen SC; Jong YJ; Tok TS; Hsu CF; Schouten EJ; Makombe SD; Yu JK; Harries AD Int J Tuberc Lung Dis; 2007 May; 11(5):534-8. PubMed ID: 17439677 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of tuberculosis patients who start antiretroviral therapy under routine programme conditions in Malawi. Makombe SD; Harries AD; Yu JK; Hochgesang M; Mhango E; Weigel R; Pasulani O; Fitzgerald M; Schouten EJ; Libamba E Int J Tuberc Lung Dis; 2007 Apr; 11(4):412-6. PubMed ID: 17394687 [TBL] [Abstract][Full Text] [Related]
9. Challenges to the success of HIV and tuberculosis care and treatment in the public health sector in South Africa. Dong K; Thabethe Z; Hurtado R; Sibaya T; Dlwati H; Walker B; Wilson D J Infect Dis; 2007 Dec; 196 Suppl 3():S491-6. PubMed ID: 18181699 [TBL] [Abstract][Full Text] [Related]
10. Voluntary counselling, HIV testing and adjunctive cotrimoxazole are associated with improved TB treatment outcomes under routine conditions in Thyolo District, Malawi. Chimzizi R; Gausi F; Bwanali A; Mbalume D; Teck R; Gomani P; Zachariah R; Zuza W; Malombe R; Salaniponi FM; Harries AD Int J Tuberc Lung Dis; 2004 May; 8(5):579-85. PubMed ID: 15137534 [TBL] [Abstract][Full Text] [Related]
11. Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi. Mwaungulu FB; Floyd S; Crampin AC; Kasimba S; Malema S; Kanyongoloka H; Harries AD; Glynn JR; Fine PE Bull World Health Organ; 2004 May; 82(5):354-63. PubMed ID: 15298226 [TBL] [Abstract][Full Text] [Related]
13. Measurement and determinants of tuberculosis outcome in Karonga District, Malawi. Glynn JR; Warndorff DK; Fine PE; Munthali MM; Sichone W; Pönnighaus JM Bull World Health Organ; 1998; 76(3):295-305. PubMed ID: 9744250 [TBL] [Abstract][Full Text] [Related]
14. Counselling, HIV testing and adjunctive cotrimoxazole for TB patients in Malawi: from research to routine implementation. Chimzizi RB; Harries AD; Manda E; Khonyongwa A; Salaniponi FM Int J Tuberc Lung Dis; 2004 Aug; 8(8):938-44. PubMed ID: 15305474 [TBL] [Abstract][Full Text] [Related]
15. WHO clinical staging of HIV infection and disease, tuberculosis and eligibility for antiretroviral treatment: relationship to CD4 lymphocyte counts. Teck R; Ascurra O; Gomani P; Manzi M; Pasulani O; Kusamale J; Salaniponi FM; Humblet P; Nunn P; Scano F; Harries AD; Zachariah R Int J Tuberc Lung Dis; 2005 Mar; 9(3):258-62. PubMed ID: 15786887 [TBL] [Abstract][Full Text] [Related]
16. Declining prevalence of drug-resistant tuberculosis among HIV/tuberculosis co-infected patients receiving antiretroviral therapy. Sungkanuparph S; Eampokalap B; Chottanapund S; Bed ST; Manosuthi W J Med Assoc Thai; 2007 May; 90(5):884-8. PubMed ID: 17596041 [TBL] [Abstract][Full Text] [Related]
17. Compliance with cotrimoxazole prophylaxis for the prevention of opportunistic infections in HIV-positive tuberculosis patients in Thyolo district, Malawi. Zachariah R; Harries AD; Arendt V; Wennig R; Schneider S; Spielmann M; Panarotto E; Gomani P; Salaniponi FM Int J Tuberc Lung Dis; 2001 Sep; 5(9):843-6. PubMed ID: 11573896 [TBL] [Abstract][Full Text] [Related]
18. Preventing recurrent tuberculosis in high HIV-prevalent areas in sub-Saharan Africa: what are the options for tuberculosis control programmes? Harries AD; Chimzizi RB; Nyirenda TE; van Gorkom J; Salaniponi FM Int J Tuberc Lung Dis; 2003 Jul; 7(7):616-22. PubMed ID: 12870681 [TBL] [Abstract][Full Text] [Related]
19. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa. Harries AD; Zachariah R; Lawn SD Int J Tuberc Lung Dis; 2009 Jan; 13(1):6-16. PubMed ID: 19105873 [TBL] [Abstract][Full Text] [Related]
20. Tuberculosis and HIV interaction in sub-Saharan Africa: impact on patients and programmes; implications for policies. Maher D; Harries A; Getahun H Trop Med Int Health; 2005 Aug; 10(8):734-42. PubMed ID: 16045459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]